ZA201201528B - Compounds having tafia inhibitory activity - Google Patents
Compounds having tafia inhibitory activityInfo
- Publication number
- ZA201201528B ZA201201528B ZA2012/01528A ZA201201528A ZA201201528B ZA 201201528 B ZA201201528 B ZA 201201528B ZA 2012/01528 A ZA2012/01528 A ZA 2012/01528A ZA 201201528 A ZA201201528 A ZA 201201528A ZA 201201528 B ZA201201528 B ZA 201201528B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- inhibitory activity
- tafia inhibitory
- tafia
- activity
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009215093 | 2009-09-17 | ||
| JP2010103546 | 2010-04-28 | ||
| PCT/JP2010/066637 WO2011034215A1 (en) | 2009-09-17 | 2010-09-17 | COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201201528B true ZA201201528B (en) | 2013-05-29 |
Family
ID=43758807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2012/01528A ZA201201528B (en) | 2009-09-17 | 2012-02-29 | Compounds having tafia inhibitory activity |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120172598A1 (OSRAM) |
| EP (1) | EP2477989A4 (OSRAM) |
| JP (1) | JP2013505202A (OSRAM) |
| AR (1) | AR078424A1 (OSRAM) |
| AU (1) | AU2010296312A1 (OSRAM) |
| CA (1) | CA2773125A1 (OSRAM) |
| IN (1) | IN2012DN01966A (OSRAM) |
| NZ (1) | NZ598478A (OSRAM) |
| PH (1) | PH12012500526A1 (OSRAM) |
| SG (1) | SG179176A1 (OSRAM) |
| TW (1) | TW201121964A (OSRAM) |
| WO (1) | WO2011034215A1 (OSRAM) |
| ZA (1) | ZA201201528B (OSRAM) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003013526A1 (en) * | 2001-08-08 | 2003-02-20 | Merck & Co. Inc. | Anticoagulant compounds |
| MXPA04005940A (es) * | 2002-01-22 | 2004-09-13 | Pfizer | Acidos 3-(imidazolil)-2-aminopropanoicos. |
| JPWO2010050525A1 (ja) * | 2008-10-29 | 2012-03-29 | 大正製薬株式会社 | ＴＡＦＩａ阻害活性を有する化合物 |
-
2010
- 2010-09-16 AR ARP100103378A patent/AR078424A1/es not_active Application Discontinuation
- 2010-09-16 TW TW099131555A patent/TW201121964A/zh unknown
- 2010-09-17 PH PH1/2012/500526A patent/PH12012500526A1/en unknown
- 2010-09-17 JP JP2012506827A patent/JP2013505202A/ja not_active Withdrawn
- 2010-09-17 SG SG2012018644A patent/SG179176A1/en unknown
- 2010-09-17 US US13/496,625 patent/US20120172598A1/en not_active Abandoned
- 2010-09-17 IN IN1966DEN2012 patent/IN2012DN01966A/en unknown
- 2010-09-17 NZ NZ598478A patent/NZ598478A/xx not_active IP Right Cessation
- 2010-09-17 WO PCT/JP2010/066637 patent/WO2011034215A1/en not_active Ceased
- 2010-09-17 EP EP10817326A patent/EP2477989A4/en not_active Withdrawn
- 2010-09-17 CA CA2773125A patent/CA2773125A1/en not_active Abandoned
- 2010-09-17 AU AU2010296312A patent/AU2010296312A1/en not_active Abandoned
-
2012
- 2012-02-29 ZA ZA2012/01528A patent/ZA201201528B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN2012DN01966A (OSRAM) | 2015-08-21 |
| JP2013505202A (ja) | 2013-02-14 |
| AR078424A1 (es) | 2011-11-09 |
| US20120172598A1 (en) | 2012-07-05 |
| PH12012500526A1 (en) | 2012-10-22 |
| SG179176A1 (en) | 2012-04-27 |
| NZ598478A (en) | 2013-01-25 |
| EP2477989A1 (en) | 2012-07-25 |
| CA2773125A1 (en) | 2011-03-24 |
| WO2011034215A1 (en) | 2011-03-24 |
| AU2010296312A1 (en) | 2012-03-29 |
| EP2477989A4 (en) | 2013-03-13 |
| TW201121964A (en) | 2011-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2277881A4 (en) | HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K | |
| GB0908293D0 (en) | Herbicidal compounds | |
| GB0905441D0 (en) | Herbicidal compounds | |
| GB0907425D0 (en) | Compounds | |
| EP2393493A4 (en) | LINKS | |
| GB0907515D0 (en) | Compounds | |
| ZA201203414B (en) | Active compound combinations | |
| GB0917934D0 (en) | Herbicidal compounds | |
| GB0905641D0 (en) | Compounds | |
| GB0909671D0 (en) | Compounds | |
| ZA201103269B (en) | COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY | |
| GB0915519D0 (en) | Ntithrombotic compounds | |
| GB0909672D0 (en) | Compounds | |
| ZA201203193B (en) | Amidoacetonitrile compounds having pesticidal activity | |
| AP2909A (en) | Pyrazinoisoquinoline Compounds | |
| GB0916267D0 (en) | Herbicidal compounds | |
| EP2443115A4 (en) | COMPOUNDS | |
| ZA201201528B (en) | Compounds having tafia inhibitory activity | |
| EP2463292A4 (en) | COMPOUND HAVING NEURITY EXCROTING ACTIVITY | |
| GB0917650D0 (en) | Anti[rotozoal activity | |
| GB0917407D0 (en) | Herbicidal compounds | |
| GB0905963D0 (en) | Herbicidal compounds | |
| PL387504A1 (pl) | Rozsiewacz | |
| GB0905932D0 (en) | Compounds | |
| GB0909912D0 (en) | Compounds |